These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 937994)

  • 1. Spectrophotofluorometric method for quantitative determination of sulpiride in human plasma and urine.
    Kleimola T; Leppänen O; Kanto J; Mäntylä R; Syvälahti E
    Ann Clin Res; 1976 Apr; 8(2):104-10. PubMed ID: 937994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vivo bioequivalence study of Sulpirid (GYKI-Alkaloida) and Dogmatil fort (Delagrange) 200 mg sulpiride tablets in healthy volunteers].
    Tomori L; Vereczkey L; Past T; Singer J; Mészáros S
    Acta Pharm Hung; 1992; 62(1-2):39-46. PubMed ID: 1566638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the bioavailability of digoxin in capsule, tablet, and solution taken orally with intravenous digoxin.
    Binnion PF
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):461-7. PubMed ID: 977789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of sulpiride and its alkaline degradation product by second derivative synchronous fluorescence spectroscopy.
    Abdelal A; El-Enany N; Belal F
    Talanta; 2009 Dec; 80(2):880-8. PubMed ID: 19836568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bioavailability of sulpiride taken as a film-coated tablet with sodium bicarbonate, cimetidine, natural orange juice or hydrochloric acid.
    Shinkuma D; Hamaguchi T; Kobayashi M; Yamanaka Y; Mizuno N
    Int J Clin Pharmacol Ther Toxicol; 1989 Oct; 27(10):499-502. PubMed ID: 2555311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability study of a new amoxicillin tablet designed for several modes of oral administration.
    Cortvriendt WR; Verschoor JS; Hespe W
    Arzneimittelforschung; 1987 Aug; 37(8):977-9. PubMed ID: 3675699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute pharmacokinetic and pharmacodynamic comparison of two different formulations of temazepam.
    Mattila MJ; Mattila M; Tuomainen P
    Med Biol; 1985; 63(1):21-7. PubMed ID: 2860283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of food intake on the bioavailability of sulpiride from AEA film-coated tablet having a pH-dependent dissolution characteristic in normal or drug-induced achlorhydric subjects.
    Shinkuma D; Hamaguchi T; Kobayashi M; Yamanaka Y; Mizuno N
    Int J Clin Pharmacol Ther Toxicol; 1991 Aug; 29(8):303-9. PubMed ID: 1743804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability of sulpiride tablet and capsule in dogs.
    Alam AS; Hagerman LM; Imondi AR
    Arch Int Pharmacodyn Ther; 1980 Oct; 247(2):180-9. PubMed ID: 7447564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects.
    Henney HR; Shah J
    Clin Ther; 2007 Apr; 29(4):661-9. PubMed ID: 17617289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers.
    Shah J; Wesnes KA; Kovelesky RA; Henney HR
    Clin Ther; 2006 Sep; 28(9):1308-17. PubMed ID: 17062304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and evaluation of a controlled-release theophylline tablet. Preliminary communication.
    Gai MN; Pezoa R; Corbeaux J; Arancibia A
    Farmaco; 1989 Nov; 44(11):1119-26. PubMed ID: 2701966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dogmatil and vertigo in the aged subject. Apropos of 10 years' prescribing].
    Lebon P
    Sem Hop; 1983 Nov; 59(43):3015-7. PubMed ID: 6320387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability of indomethacin tablets in men volunteers.
    Groth PE; Dunn JM
    Clin Pharm; 1986 Oct; 5(10):820-4. PubMed ID: 3780150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of ergoloid mesylates liquid capsule.
    Schran HF
    Clin Ther; 1985; 8(1):71-5. PubMed ID: 3833371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in nifedipine concentration-effect relationship between capsule and slow release tablet administration.
    Castañeda-Hernández G; Hoyo-Vadillo C; Herrera JE
    Int J Clin Pharmacol Ther; 1995 Jan; 33(1):56-60. PubMed ID: 7711994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative pharmacokinetics and antihypertensive effects of the nifedipine tablet and capsule.
    Myers MG; Raemsch KD
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S76-8. PubMed ID: 2455148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absolute bioavailability of quinine formulations in Nigeria.
    Babalola CP; Bolaji OO; Ogunbona FA; Ezeomah E
    Afr J Med Med Sci; 2004 Sep; 33(3):185-9. PubMed ID: 15819461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suprofen sustained release kinetics in healthy male volunteers. 1st communication: a single dose open crossover bioavailability study of suprofen sustained release tablets versus capsules.
    Michos N; Zulliger HW; Barkworth MF; Johnson KJ; Rehm KD; Töberich H; Klein G
    Arzneimittelforschung; 1986 Jun; 36(6):941-8. PubMed ID: 3741528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmaceutical and biological availability of commercial preparations of furosemide.
    Stüber W; Mutschler E; Steinbach D
    Arzneimittelforschung; 1982; 32(6):693-7. PubMed ID: 6889429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.